Seres Therapeutics and Nestlé Health Science Present Late-Breaking Data on VOWST™, a Microbiota-Based Oral Therapeutic for Prevention of Recurrence of C. Difficile Infection in Adults, at ASM Microbe 2023
CAMBRIDGE, Mass. & HOBOKEN, N.J.--(BUSINESS WIRE)--Jun 17, 2023--